PE-22-28 10mg

Research Specifications

Sequence:
Lys-Gln-Glu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr (PE 22-28, 13 aa)
Parent:
Spadin (17-aa fragment of sortilin propeptide)
Molecular weight:
~1700 Da
Vial:
10mg lyophilized
Purity:
≥98% HPLC verified

PE-22-28 10mg

Spadin 17-amino-acid sortilin propeptide fragment

CAS: 1404-08-3

Days

Antidepressant onset

Mazella 2010

TREK-1

Selective target

Heurteaux 2006

Spadin 22-28

Fragment origin

Sortilin cleavage

Receptor Targets

TREK-1 (KCNK2)Background K+ channel blockade → neuronal depolarization
$71.99In Stock
Buy Now
≥98% Purity Verified Free Shipping $200+ HPLC Tested
Preclinical

Preclinical novel antidepressant research

No human clinical trials. Active preclinical research tool for TREK-1 biology and rapid-onset antidepressant mechanisms.

Also Known As

PE-22-28Spadin(22-28)TREK-1 blocker peptideSortilin-derived antidepressant fragment

Reconstitution & Dosing Guide

BAC Water

2mL

Final Concentration

5 mg/mL

Per Dose

100 μg = 0.02 mL (2 IU)

Rodent-protocol-derived dosing; human-research-equivalent exploratory

Published References

  1. 1.
    Mazella J, Pétrault O, Lucas G, et al.. Spadin, a sortilin-derived peptide, targeting rodent TREK-1 channels: a new concept in the antidepressant drug design. PLoS Biology (2010) PMID: 20859533
  2. 2.
    Heurteaux C, Lucas G, Guy N, et al.. Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype. Nature Neuroscience (2006) PMID: 17086178

Research Use Only. This product is intended for in-vitro laboratory research only. Not for human consumption, injection, or therapeutic use. Not medical advice. Always consult applicable regulations in your jurisdiction.

Price Comparison

SupplierPurityPriceShipping
our verified supplier>98% HPLC$71.99Free over $200
Generic Research SuppliersVaries (often <95%)Similar–HigherVaries
Pharmaceutical (Rx only)Pharmaceutical gradeNot available for researchRx required

PE-22-28 10mg

$71.99

Buy Now